You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Nanoparticle Drones to Target Lung Cancer with Radiosensitizers and Cannabinoids
|
|---|---|
| Published in |
Frontiers in oncology, September 2017
|
| DOI | 10.3389/fonc.2017.00208 |
| Pubmed ID | |
| Authors |
Wilfred Ngwa, Rajiv Kumar, Michele Moreau, Raymond Dabney, Allen Herman |
| Abstract |
Nanotechnology has opened up a new, previously unimaginable world in cancer diagnosis and therapy, leading to the emergence of cancer nanomedicine and nanoparticle-aided radiotherapy. Smart nanomaterials (nanoparticle drones) can now be constructed with capability to precisely target cancer cells and be remotely activated with radiation to emit micrometer-range missile-like electrons to destroy the tumor cells. These nanoparticle drones can also be programmed to deliver therapeutic payloads to tumor sites to achieve optimal therapeutic efficacy. In this article, we examine the state-of-the-art and potential of nanoparticle drones in targeting lung cancer. Inhalation (INH) (air) versus traditional intravenous ("sea") routes of navigating physiological barriers using such drones is assessed. Results and analysis suggest that INH route may offer more promise for targeting tumor cells with radiosensitizers and cannabinoids from the perspective of maximizing damage to lung tumors cells while minimizing any collateral damage or side effects. |
X Demographics
The data shown below were collected from the profiles of 53 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 8 | 15% |
| Canada | 4 | 8% |
| Portugal | 3 | 6% |
| Switzerland | 2 | 4% |
| Australia | 1 | 2% |
| South Africa | 1 | 2% |
| Iceland | 1 | 2% |
| Unknown | 33 | 62% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 48 | 91% |
| Practitioners (doctors, other healthcare professionals) | 3 | 6% |
| Scientists | 1 | 2% |
| Unknown | 1 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 66 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 66 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 12 | 18% |
| Researcher | 11 | 17% |
| Student > Ph. D. Student | 10 | 15% |
| Student > Bachelor | 5 | 8% |
| Student > Doctoral Student | 4 | 6% |
| Other | 4 | 6% |
| Unknown | 20 | 30% |
| Readers by discipline | Count | As % |
|---|---|---|
| Pharmacology, Toxicology and Pharmaceutical Science | 8 | 12% |
| Agricultural and Biological Sciences | 6 | 9% |
| Medicine and Dentistry | 6 | 9% |
| Biochemistry, Genetics and Molecular Biology | 4 | 6% |
| Physics and Astronomy | 4 | 6% |
| Other | 15 | 23% |
| Unknown | 23 | 35% |
Attention Score in Context
This research output has an Altmetric Attention Score of 249. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 January 2024.
All research outputs
#151,224
of 25,721,020 outputs
Outputs from Frontiers in oncology
#23
of 22,767 outputs
Outputs of similar age
#3,170
of 326,277 outputs
Outputs of similar age from Frontiers in oncology
#1
of 97 outputs
Altmetric has tracked 25,721,020 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,767 research outputs from this source. They receive a mean Attention Score of 3.1. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 326,277 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 97 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.